TREA

88751609 - LEVIMMUNE

Follow

Information

  • Trademark
  • 88751609
  • Serial Number
    88751609
  • Filing Date
    January 08, 2020
    5 years ago
  • Transaction Date
    February 07, 2024
    a year ago
  • Status Date
    March 07, 2022
    3 years ago
  • Published for Opposition Date
    June 09, 2020
    4 years ago
  • Location Date
    August 04, 2020
    4 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    OWCZARSKI, KAREN ESTIL
  • Attorney Docket Number
    230042.206
    Attorney Name
    Jared M. Barrett
    Law Office Assigned Location Code
    O20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
LEVIMMUNE
Case File Statements
  • GS0051: Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
  • GS0441: Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
  • GS0421: Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
Case File Event Statements
  • 3/7/2022 - 3 years ago
    29 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/7/2022 - 3 years ago
    28 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 7/15/2021 - 3 years ago
    27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/13/2021 - 3 years ago
    26 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 7/13/2021 - 3 years ago
    25 - SOU EXTENSION 2 FILED Type: EXT2
  • 7/13/2021 - 3 years ago
    24 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/12/2021 - 4 years ago
    23 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/8/2021 - 4 years ago
    22 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/8/2021 - 4 years ago
    21 - SOU EXTENSION 1 FILED Type: EXT1
  • 1/8/2021 - 4 years ago
    20 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 8/4/2020 - 4 years ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 6/9/2020 - 4 years ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/9/2020 - 4 years ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/20/2020 - 4 years ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/4/2020 - 4 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 4/24/2020 - 4 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/24/2020 - 4 years ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/24/2020 - 4 years ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/24/2020 - 4 years ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/24/2020 - 4 years ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/22/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/21/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/21/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/28/2020 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/28/2020 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/28/2020 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/13/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/11/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP